Online Colloquium: “Therapeutic Opportunities in Glycoscience” — February 11, 2021 at 4 PM
Dr. Carolyn Bertozzi
Baker Family Co-Director, Stanford ChEM-H
Anne T. and Robert M. Bass Professor of Chemistry
Professor of Chemical & Systems Biology and Radiology (by courtesy)
Department of Chemistry and Howard Hughes Medical Institute
Thursday, February 11, 2021, 4 PM EST
Via Video Conference (contact email@example.com for link information)
All interested persons are cordially invited to join the Zoom call.
Cell surface glycans constitute a rich biomolecular dataset that drives both normal and pathological processes. Their “readers” are glycan-binding receptors that can engage in cell-cell interactions and cell signaling. Our research focuses on mechanistic studies of glycan/receptor biology and applications of this knowledge to new therapeutic strategies. Our recent efforts center on pathogenic glycans in the tumor microenvironment and new therapeutic modalities based on the concept of targeted degradation.
Carolyn Bertozzi is the Baker Family Director of Stanford ChEM-H and the Anne T. and Robert M. Bass Professor of Humanities and Sciences in the Department of Chemistry at Stanford University. She is also an Investigator of the Howard Hughes Medical Institute. Her research focuses on profiling changes in cell surface glycosylation associated with cancer, inflammation and infection, and exploiting this information for development of diagnostic and therapeutic approaches, most recently in the area of immuno-oncology. She is an elected member of the National Academy of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences. She also has been awarded the Lemelson-MIT Prize, a MacArthur Foundation Fellowship, the Chemistry for the Future Solvay Prize, among many others.
Professional Website https://chemistry.stanford.edu/people/carolyn-bertozzi